Recently, researchers have developed protocols for human cerebral organoids using human pluripotent stem cells, which mimic the structure of the developing human brain. Existing research demonstrated that human cerebral organoids which undergo short cultivation periods, contain astrocytes, neurons, and neural stem cells, but lacked mature oligodendrocytes, and mature, fully functional neurons. In this study, we analyzed organoids induced from H9 human embryonic stem (ES) cells that were cultivated for as long as six months. We observed mature oligodendrocytes, positive for MBP (myelin-basic protein), and mature GAD67 (glutamate decarboxylase 67 kDa isoform)-positive inhibitory neurons and VGLUT1 (vesicular glutamate transporter 1)-positive excitatory neurons via immunohistochemical analysis. These observations suggest that long-term cultivation of cerebral organoids can lead to the maturation of human cerebral organoids, which can be used as a tool to study the development of human brains.
Introduction
Pluripotent stem cells, such as embryonic stem (ES) cells (ESCs) [1] [2] [3] and induced pluripotent stem cells [4] [5] [6] , are known to give rise to almost all the cells found in the three germ layers, and a number of research groups have since published protocols on the induction of various cell types from human ES cells using 2D cultures, based on finetuned growth factors. The inability to replicate the growth of organs in a 3D environment based on such 2D cultures is a limitation that has prompted recent attempts in the development of tissue organoids that mimic the multicellular structure of selected organs, such as the human brain [7] [8] [9] [10] [11] , colon [12] , kidney [13] , and retina [14, 15] .
In particular, the mammalian cerebral cortex is developed in a 3D environment during the embryonic period and composed of many layers of neuronal cells, growing with well-tuned interactions mediated by cell-cell signaling or the secretion of various growth factors. Its complex development makes it difficult to analyze these structures by 2D in vitro culture methods. As is known in the field of human brain research, the human brain has a more complex structure than that of a mouse, thus making it challenging to recapitulate the rapid expansion of the cortex in the developing human brain using mouse models [16, 17] . Therefore, 3D-cultured human cerebral organoids are expected to become a powerful tool to analyze the complex developing human brain without the associated ethical concerns in acquiring human tissue samples [18] .
Currently, human cerebral organoids have been demonstrated to recapitulate some of the earliest stages of human embryonic brain development [19] . Additionally, neuronal populations show maturation during extended cultivation. One group revealed that six-month-old cerebral organoids contain mature astrocytes and mature neurons, such as putative callosal, and putative corticofugal neurons, via single-cell RNA sequencing [20] . They also detected neurons with synapses, and spontaneously active neuronal networks in cerebral organoids that were cultivated for as long as eight months [20] . A separate research group reported the maturation of cerebral organoids after about eight months of cultivation [21] . They observed oligodendrocyte progenitor cells (OPC) expressing OPC markers, such as O4 (O antigen 4) and OLIG1
(oligodendrocyte transcription factor 1), by immunohistochemistry. It is of note, however, that no group has reported mature oligodendrocytes with MBP expression. In the present study, we intended to induce maturation of human cerebral organoids after an extended six-month cultivation. We expect that human cerebral organoids will enable us to analyze the mechanism of many diseases starting from the later phases of prenatal brain development [22] , as well as demyelinating brain injuries/diseases [23, 24] . In addition, we expect that the normal process of human brain development and maturation can be analyzed by long-term culture of human cerebral organoids [21] .
In this study, we examined the maturation of human cerebral organoids after an extended period of culture. Our findings highlight the novel possibility of human cerebral organoids for research of human brain development, leukodystrophies, hereditary epilepsies, and various demyelinating diseases.
Materials and methods

Maintenance of ES cells
Human H9 ESC line (46XX, WA09, WiCell Research Institute, Madison, WI, USA [1] ) was purchased from WiCell and maintained in mTeSRTM1 medium (05851, Stemcell Technologies) based on feederfree culture protocols on six-well plates (3506, Corning) coated with growth factor-reduced Matrigel (356230, BD Biosciences) with Rho Kinase (ROCK) inhibitor (final concentration 10 μM, S-1049, Selleck Chemicals). The cells were maintained with daily medium change without ROCK inhibitor until they reached about 70% confluency. They were then detached using versene solution (15040-066, Thermo Fisher Scientific) and seeded with a ratio of 1:20.
Cerebral organoid development
Human ES cells were detached and subjected to embryoid body (EB) induction based on a published protocol with a slight modifications [11, 22] . ESCs were briefly detached using versene and accutase (A6964, Sigma), dissociated into single cells and suspended at 60 cells/ μl in 150 μl of the human EB medium (DMEM/F12, 3% FBS, 20% knockout serum replacement, 1 × non-essential amino acids, 1 × Glutamax, and 2-mercaptoethanol) in 96-well clear round bottom ultra-low attachment microplates (7007, Corning). The medium was supplemented with ROCK inhibitor (final concentration 50 μM) and basic fibroblast growth factor (bFGF) (final concentration 4 ng/ml). After six days, each EBs was transferred to an individual well in a 24-well ultralow attachment plate (3473, Corning), filled with 500 μl of neural induction medium (NIM) per well, composed of DMEM-F12 with 1 × N2 supplement (17502048, Thermo Fisher Scientific), 1 × Glutamax, 1 × non-essential amino acids and heparin (1 μg/ml), and embedded in Matrigel after 5 days. The organoids were induced in organoid medium, described in previously published papers [11, 22] , on an orbit shaker. The organoid size was analyzed by measuring the area using ImageJ software.
Immunohistochemical analysis
Each human cerebral organoids was fixed in 4% paraformaldehyde in Phosphate-Buffered Saline (PBS) overnight at 4°C, dehydrated with 30% sucrose in PBS and embedded in OCT Compound (23-730-571, Thermo Fisher Scientific). Cryostat sections (14 μm) were cut and mounted onto slides (Thermo Fisher Scientific). Mounted sections were incubated for 1 h at room temperature with blocking solution [3% normal donkey serum + 0.3% Triton X-100 in Tris-Buffered Saline (TBS)] and incubated with primary antibodies diluted in blocking solution overnight at 4°C. After three washes with TBS, corresponding fluorophore-conjugated secondary antibodies diluted in the blocking solution were added and incubated for 2 h at room temperature and followed by DAPI staining. Finally, stained slides were rinsed with TBS three times, mounted and analyzed using a Nikon A1R confocal microscope equipped with four laser lines (405, 488, 561 and 633 nm) under 20× and 40× objective lenses. Serial Z-stack images were obtained and collapsed to obtain a maximum intensity projection of lines. Antibodies specific for TUJ1 (1:400, T8660) and S100β (1:200, S2532) purchased from Sigma, GFAP (1:1000, Z0334) from DAKO, DCX (1:500, SC8066), SOX10 (1:500, SC17343) and SOX2 (1:500, Y17) from SantaCruz, MBP (1:500, AB980) and OLIG2 (1:500, AB9610) and GAD67 (1:500, AB5992) from Millipore, VGLUT1 (1:500, 135-303) from synaptic systems, and AC3 (1:400, D175) from Cell Signaling were used for immunostaining.
RNA isolation, RT-PCR and quantitative PCR
RNA from human cerebral organoids and ES cells was extracted according to the protocol supplied with TRIzol reagent (15596018, Thermo Fisher Scientific). The concentration and purity of the RNA samples were measured by using DU730 UV-vis Spectrophotometer (Beckman Coulter). The extracted RNA (1 μg) was reverse transcribed according to the protocol supplied with ReverTra Ace qPCR RT Master Mix (FSQ-201, TOYOBO). StepOne Plus Real-time PCR System (Thermo Fisher Scientific) was used to amplify and quantify levels of target gene cDNA. Quantitative real-time PCR (qRT-PCR) was performed with SsoAdvanced Universal SYBR Green Supermix (172-5271, Bio-Rad Laboratories) and specific primers for qRT-PCR. Reactions were run in triplicate and the expression of each gene was normalized to the geometric mean of β-actin as a housekeeping gene and analyzed using the 
Statistics
Unpaired two-tailed Student's t-tests were used to compare sets of organoid volume and qRT-PCR data. All statistical analyses were carried out using Prism version 7 (Graphpad software Inc., San Diego, CA).
Results
Establishment and growth of human cerebral organoids from ES cells
To analyze the maturation of human cerebral organoids, we established human cerebral organoids from H9 human ES cells as described in Lancaster's protocol [7, 8] (Fig. 1 , see more details in the methods). This protocol uses only one external growth factor [basic fibroblast growth factor (bFGF)], and the growth of cerebral organoids in this protocol is dependent on the autonomous secretion of growth factors; this protocol is used to mimic the developing embryonic human brain. After establishing the cerebral organoids from human ES cells, we cultured them for up to six months to study the effects of extended culture on these organoids (Fig. 1) . ES cells are derived from the inner cell mass in human blastocysts, formed around 5 days after fertilization 
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Neuroscience Letters 670 (2018) 75-82 [1, 27] , and after one to two months of organoid induction, their gene expression profile becomes close to that of human fetal brains 8-9 weeks after fertilization [28] . Consistent with Lancaster's study [8] where initial gradual increases in the volume of human cerebral organoids were observed before a depletion of the neural stem cell population, an analysis of the size of our cerebral organoids revealed a gradual increase in size during the initial two months ( Fig. 2A and B) and this volume-growth stopped subsequently. This is probably due to the depletion of neural stem cells and the limitation of the nutrition delivery, caused by the lack of vascular system in the human cerebral organoids.
Maturation of neural cells in cerebral organoids between one and six months old
First, to confirm whether the formed cerebral organoids contained neural cells, we carried out immunohistochemical analysis to detect various neural cells in the cell clusters formed after one month of cultivation (Fig. 3) . We found that the cell clusters from one month culture contained tubulin beta 3 class III (TUJ1)-positive neuronal cells Fig. 3 . Immunohistological analysis of 1-month-old organoids by neuronal marker TUJ1 (A), neuroblast marker DCX (B), astrocyte/radial glial marker GFAP (red) and astrocyte/ependymal cell marker S100β (green) (C), neural stem cell marker SOX2 (green) and apoptotic cell marker AC3 (red) (D), neural progenitor/oligodendrocyte progenitor marker OLIG2 (red) (E), and oligodendrocyte progenitor marker SOX10 (green) (F), stained individually (representative from > 3 organoids). In each panel, cell nuclei were stained by DAPI (blue). Bars = 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Neuroscience Letters 670 (2018) [75] [76] [77] [78] [79] [80] [81] [82] ( Fig. 3A) , Doublecortin (DCX)-positive neuroblasts (Fig. 3B) , glial fibrillary acidic protein (GFAP)-positive astrocytes and radial glial cells ( Fig. 3C ; red), S100 calcium binding protein B (S100β)-positive astrocytes and ependymal cells ( Fig. 3C ; green), SRY-Box2 (SOX2)-positive neural stem cells ( Fig. 3D ; green), oligodendrocyte transcription factor 2 (OLIG2)-positive (Fig. 3E) or SRY-Box 10 (SOX10)-positive oligodendrocyte progenitor-like cells (Fig. 3F) , and a few apoptotic cells positive for activated Caspase-3 (AC3) (Fig. 3D) , all of which were observed in developing human brains [16, [29] [30] [31] . Thereafter, to analyze the maturation of the cell population present in human cerebral organoids cultured for an extended period of time, we carried out qRT-PCR and immunohistochemical analysis to identify any mature neuronal and glial cell types. We first analyzed mRNA expression of GAD67, the marker for matured GABAergic inhibitory neurons in human ES cells, human cerebral organoids at the age of one or two month, and human brain, by qRT-PCR. GAD67 mRNA was detected only in human brain, and none of the other samples expressed GAD67. Later, we tried immunohistochemical analysis and found that the 6-month-old human cerebral organoids contained GAD67-positive inhibitory neurons (detectable in human fetus 15 weeks after conception [32] ) (Fig. 4) .
We subsequently analyzed the mRNA expression of vesicular glutamate transporter 1 (VGLUT1), the marker for excitatory neurons, by qRT-PCR, and detected the expression in two-month-old cerebral organoids (n = 3-4/each group) (Fig. 5A) , though adult human brain expressed 12.8 times more compared to two-month-old cerebral organoids. Immunohistochemical analysis also revealed that six-month-old cerebral organoids contained VGLUT1-positive mature excitatory neurons (emerging around 25 weeks after conception during normal human development [33] ) (Fig. 5B) .
Finally, we analyzed the expression of myelin-basic protein (MBP), the marker for matured oligodendrocytes (usually observed in the human fetus 28 weeks after conception [34] ), and observed an insignificant tendency of the increase in mRNA expression in the course of organoid cultivation (n = 3-4/each group, p = 0.08 between ESCs and two-month-old organoids; Fig. 6A ), while adult human brain expressed MBP mRNA > 10,000 times more than two-month-old cerebral organoids. By immunohistochemical analysis, we revealed that six-monthold organoids contain MBP-expressing mature oligodendrocytes, and that these cells were absent in one-month-old organoids (Fig. 6B and C) . Some MBP-expressing oligodendrocytes overlapped with TUJ1-positive neurons, indicating that some neurons were surrounded by oligodendrocytes, forming a myelin sheath (Fig. 6D) , which mimicked the myelination observed in prenatal human brains [35] . Consistent with an existing study [8] , cell-poor regions that are reminiscent of the marginal zone in developing human brains, would be distinguishable in long-cultivated human cerebral organoids (Fig. 6B and D) , and form layered structures such as that observed in human developing brains. In our long-cultivated organoids, within the cell-poor region, MBP-positive mature oligodendrocytes were abundant in relatively cell-rich layer, and suggests a mimicking of the sublplate layer and intermediate zone, where late OPC and mature oligodendrocytes are located in prenatal human brains [35] .
Discussion
Our findings have expanded the possibility of research using human cerebral organoids, as we have shown that they can further maturate Fig. 4 . Immunohistological analysis of 6-month-old organoids by inhibitory neuronal marker GAD67 (red) and nucleus marker DAPI (blue). Marked region in (A) was enlarged in (B), and two marked areas in (B) were enlarged in (C). Bars = 100 μm. Images are the representative from 3 organoids. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Neuroscience Letters 670 (2018) [75] [76] [77] [78] [79] [80] [81] [82] after extended cultivation and recapitulate the cell populations found in the developing human brain at about six months post conception, considering the differentiation of MBP-positive oligodendrocytes. Our findings highlight the potential use of human cerebral organoids in the study of human brain development as well as many as-yet untreatable diseases, such as congenital hypomyelinating leukodystrophy [36, 37] , hereditary epilepsies [38] , and demyelinating diseases [39] . We successfully detected the presence of matured oligodendrocytes, as well as functionally differentiated neurons in long-term human cerebral organoid cultures. To the best of our knowledge, this is the first time the presence of mature oligodendrocytes in human cerebral organoids has been observed, given a limited use of external growth factor supplementation. Our results indicate that even without finetuning external growth factors, human cerebral organoids are capable of maturing on their own, and suggest the presence of a potential mechanism by which cell-cell signaling and intrinsic secretion of growth factors guide neuronal and oligodendroglial development.
Currently, there are many untreatable congenital hypomyelinating leukodystrophies caused by improper developmental myelination, such as Pelizaeus-Merzbacher disease [40] or Allan-Herndon-Dudleys syndrome [41] . Some of the causative gene mutations have already been identified, making their recapitulation in cerebral organoid culture possible using CRISPR/Cas9-mediated gene editing [42] . An examination of organoids with extended culture periods may allow us to uncover the underlying pathology of these diseases, and potentially to screen drug candidates used in the treatment of these diseases, as we expect these organoids to recapitulate the onset of myelination failure in these diseases.
We also believe that these long-term cultured cerebral organoids with mature oligodendrocytes may be able to model demyelination caused by brain injury [43] , hypoxia [44] , toxins [45] , or various autoimmune disorders [46] , and become a powerful tool in the screening of effective drug molecules toward treating these demyelination disorders of the central nervous system. Furthermore, the detection of excitatory and inhibitory neurons in long-term cultured cerebral organoids suggest that our results have the potential to shed light on research in the field of epilepsy [47] and autism [48] , which are related to an imbalance of excitatory and inhibitory neurons. Considering the fact that matured cerebral organoids have many cell components observed in postnatal brains, it is also possible to establish a brain tumor-related carcinogenesis model [49] , where organoids are subjected to many carcinogenic chemicals or radiation and analyzed for their resulting oncogenic effect.
Our findings demonstrate an expansion in the possibilities for the use of human cerebral organoids. Human cerebral organoids can be used as a platform for recapitulating not only the early phases of embryonic human brain development, but also later periods, such as the differentiation of oligodendrocytes and functional neurons; the defects which cause epilepsy or hypomyelination; the imbalance between excitatory and inhibitory neurons that causes seizures; and the improper differentiation of oligodendrocytes that leads to myelination failures.
Finally, there are two significant issues yet to be addressed in this protocol: the lack of i) vascularization and ii) electrophysiological interaction between cells in cerebral organoids. With future developments of protocols optimized for the vascularization of human cerebral organoids with significant electrophysiological activity, it is possible that we may be able to analyze the function of the blood-brain barrier and neuronal activity in neurons present in the organoids. We also hope that vascularization may improve nutrition delivery and give rise to further functional maturation of cerebral organoids.
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